Stage 4 adrenal gland cancer (pheochromocytoma) is an advanced oncological condition characterized by the spread of tumor cells originating from the adrenal glands to distant tissues. The metastatic symptoms that arise during this process result both from the physical effects in the organs to which the mass has spread and from the systemic fluctuations caused by excessive stress hormones released into the bloodstream. At this stage of the disease, life expectancy varies across a wide range depending on the biological characteristics of the tumor, its genetic mutation profile, and the success of current oncological treatments, particularly cytoreductive surgery. A properly planned urological approach and close follow-up may directly improve both life expectancy and quality of life.<\/p>\n
| What Is Stage 4 Adrenal Gland Cancer (Metastatic Pheochromocytoma)?<\/span><\/td>\n | Stage 4 pheochromocytoma is the most advanced stage in which the tumor has spread beyond the adrenal gland. Metastases may most commonly occur in the bones, liver, lungs, and distant lymph nodes. Because pheochromocytomas may secrete hormones (catecholamines), symptoms related to both metastasis and excessive hormone production may occur.<\/span><\/td>\n<\/tr>\n| Characteristics of Pheochromocytoma<\/span><\/td>\n | Pheochromocytoma is a rare neuroendocrine tumor that develops from the chromaffin cells of the adrenal gland. A diagnosis of malignant (cancerous) pheochromocytoma is made when the tumor metastasizes.<\/span><\/td>\n<\/tr>\n | Most Common Sites of Metastasis<\/span><\/td>\n | The bones, liver, lungs, distant lymph nodes, and more rarely other organs may be affected.<\/span><\/td>\n<\/tr>\n | General Symptoms<\/span><\/td>\n | Weakness, unintentional weight loss, loss of appetite, fatigue, reduced performance, and deterioration in general health may occur.<\/span><\/td>\n<\/tr>\n | Episodes of High Blood Pressure<\/span><\/td>\n | Sudden or persistent high blood pressure is one of the most important symptoms. In some patients, blood pressure rises in episodes, while in others persistent hypertension may occur.<\/span><\/td>\n<\/tr>\n | Symptoms Related to Catecholamine Excess<\/span><\/td>\n | Severe headache, palpitations, excessive sweating, tremors, feelings of anxiety, pallor, panic-like attacks, and facial flushing may develop.<\/span><\/td>\n<\/tr>\n | Cardiovascular Symptoms<\/span><\/td>\n | Rapid heartbeat, rhythm disturbances, chest pain, shortness of breath, and, if untreated, heart muscle damage or heart failure may develop.<\/span><\/td>\n<\/tr>\n | Digestive System Symptoms<\/span><\/td>\n | Nausea, vomiting, abdominal pain, constipation, and loss of appetite may occur.<\/span><\/td>\n<\/tr>\n | Symptoms of Bone Metastasis<\/span><\/td>\n | Persistent bone pain, restricted movement, pathological fractures, and neurological symptoms caused by nerve compression may develop if the spine is involved.<\/span><\/td>\n<\/tr>\n | Symptoms of Liver Metastasis<\/span><\/td>\n | Pain in the upper right abdomen, abdominal fullness, loss of appetite, jaundice, and deterioration in liver function tests may occur.<\/span><\/td>\n<\/tr>\n | Symptoms of Lung Metastasis<\/span><\/td>\n | Shortness of breath, a persistent cough, chest pain, and bloody sputum in some patients may occur.<\/span><\/td>\n<\/tr>\n | Symptoms of Lymph Node Involvement<\/span><\/td>\n | Enlargement of lymph nodes in the neck, abdomen, or groin and related pressure symptoms may occur.<\/span><\/td>\n<\/tr>\n | Hormone-Related Crisis (Catecholamine Crisis)<\/span><\/td>\n | A life-threatening condition characterized by sudden and extremely high blood pressure, severe headache, intense sweating, chest pain, serious rhythm disturbances, and altered consciousness may develop. It requires emergency medical intervention.<\/span><\/td>\n<\/tr>\n | Diagnostic Methods<\/span><\/td>\n | Measurements of metanephrines\/catecholamines in blood and 24-hour urine, computed tomography (CT), magnetic resonance imaging (MRI), PET-CT, MIBG scintigraphy, and other functional imaging methods when necessary may be used.<\/span><\/td>\n<\/tr>\n | Pathological and Genetic Evaluation<\/span><\/td>\n | Along with the characteristics of the tumor, hereditary gene mutations, particularly SDHB, may be evaluated. Genetic testing is important for treatment and family screening in many patients.<\/span><\/td>\n<\/tr>\n | Treatment Approach<\/span><\/td>\n | Treatment may include the combined planning of surgery in suitable patients, hormonal control with alpha blockers and beta blockers when necessary, chemotherapy, targeted therapies, radionuclide treatments (for example, I-131 MIBG or peptide receptor radionuclide therapy in suitable patients), radiotherapy, and supportive care.<\/span><\/td>\n<\/tr>\n | Blood Pressure Control<\/span><\/td>\n | Safely controlling blood pressure before and during treatment is of great importance. Appropriate medication preparation, particularly before surgery, reduces the risk of complications.<\/span><\/td>\n<\/tr>\n | Role of Radionuclide Treatments<\/span><\/td>\n | In patients with suitable imaging findings and tumor characteristics, radiolabeled treatments may help reduce tumor burden, relieve symptoms, and contribute to disease control.<\/span><\/td>\n<\/tr>\n | Purpose of Chemotherapy<\/span><\/td>\n | The aim in patients with advanced-stage disease is to slow tumor growth, control metastatic disease, and relieve symptoms.<\/span><\/td>\n<\/tr>\n | Role of Radiotherapy<\/span><\/td>\n | It may be applied particularly to reduce pain caused by bone metastases, lower the risk of fractures, and achieve local disease control.<\/span><\/td>\n<\/tr>\n | Palliative Care<\/span><\/td>\n | It aims to control pain, manage blood pressure, provide nutritional and psychological support, relieve symptoms, and improve quality of life. Palliative care is not limited to the final stage of life; it may be applied at every stage of the disease.<\/span><\/td>\n<\/tr>\n | Life Expectancy<\/span><\/td>\n | Life expectancy varies significantly from person to person. The extent of metastasis, the level of hormone secretion, the biological characteristics and genetic structure of the tumor, response to treatment, general health, and the treatments applied are the main factors determining prognosis. Therefore, it is not possible to provide an exact life expectancy.<\/span><\/td>\n<\/tr>\n | Factors Affecting Prognosis<\/span><\/td>\n | The organs affected by metastasis, tumor burden, genetic mutations such as SDHB, the level of hormone secretion, response to treatment, performance status, and accompanying diseases affect prognosis.<\/span><\/td>\n<\/tr>\n | Monitoring Response to Treatment<\/span><\/td>\n | The course of the disease is monitored through regular blood and urine biochemical tests, imaging methods, and clinical evaluation.<\/span><\/td>\n<\/tr>\n | Nutrition and Support<\/span><\/td>\n | A balanced diet, adequate fluid intake, protein support aimed at preventing muscle loss, appropriate physical activity, and dietitian support when necessary are recommended.<\/span><\/td>\n<\/tr>\n | Psychosocial Support<\/span><\/td>\n | Psychological counseling, social services support, and the contribution of multidisciplinary palliative care teams for patients and their relatives are important parts of the treatment process.<\/span><\/td>\n<\/tr>\n | Situations Requiring Emergency Medical Evaluation<\/span><\/td>\n | Emergency medical evaluation is required if extremely high blood pressure, unbearable headache, chest pain, severe palpitations, fainting, shortness of breath, altered consciousness, uncontrollable vomiting, sudden weakness, severe bone pain, or symptoms suggesting spinal cord compression develop.<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n | |